ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
10x Genomics Inc

10x Genomics Inc (TXG)

31,04
-2,46
(-7,34%)
Fermé 06 Juin 10:00PM
30,7747
-0,2653
(-0,85%)
Après les heures de négociation: 1:23AM

10x Genomics Inc (TXG) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
30,7747
( -8,14% )
Prix Achat
23,31
Prix Vente
38,07
Volume échangé
3 801 931
30,27 Fourchette du Jour 33,07
8,945 Plage de 52 semaines 35,645
Cap du marché
Clôture Veille
33,50
Ouverture
32,79
Dernière Transaction
10
@
30.76
Dernière heure de transaction
Volume financier
US$ 119 224 017
VWAP
31,3588
Volume moyen (3 m)
US$ 2 535 686
Actions en circulation
126 956 189
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-142,07
Bénéfice par action (BPA)
-0,18
Chiffre d'affairess (LTM)
638,78M
Bénéfice net (LTM)
-22,66M

À propos de 10x Genomics Inc

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enabl... 10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3’ gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Pleasanton, United States
Fondé
2026
10x Genomics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker TXG. Le dernier cours de clôture d'10x Genomics était de US$33,50. Au cours de la dernière année, les actions de 10x Genomics ont été négociées dans une fourchette de prix de US$ 8,945 à US$ 35,645.

10x Genomics compte actuellement 126 956 189 actions en circulation. La capitalisation boursière d'10x Genomics est de US$3,91 milliard. 10x Genomics a un ratio cours/bénéfice (ratio PE) de -142.07.

Flux d'options 10x Genomics (TXG)

Flux global

Haussier

Prime nette

556k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

200,00%

Sweeps Ratio

0,00%

TXG Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
12.954710.620776419827.8235.64527.2819331166231.07699261CS
49.704746.05932605621.0735.64519.82312622225.30438701CS
1211.904763.087970323318.8735.64515.9266971423.00089326CS
2612.754770.780799112118.0235.64515.18253595921.1552505CS
5221.3547226.6953290879.4235.6458.945285378016.6854292CS
156-23.2753-43.062534690154.0563.576.78218879020.16324259CS
260-148.5553-82.8390676407179.33208.996.78174858933.0253659CS

TXG - Frequently Asked Questions (FAQ)

What is the current 10x Genomics Inc share price?
The current share price of 10x Genomics Inc is US$ 30,7747
How many 10x Genomics Inc shares are in issue?
10x Genomics Inc has 126 956 189 shares in issue
What is the market cap of 10x Genomics Inc?
The market capitalisation of 10x Genomics Inc is USD 3,91B
What is the 1 year trading range for 10x Genomics Inc share price?
10x Genomics Inc has traded in the range of US$ 8,945 to US$ 35,645 during the past year
What is the PE ratio of 10x Genomics Inc?
The price to earnings ratio of 10x Genomics Inc is -142,07
What is the cash to sales ratio of 10x Genomics Inc?
The cash to sales ratio of 10x Genomics Inc is 5,07
What is the registered address of 10x Genomics Inc?
The registered address for 10x Genomics Inc is 6230 Stoneridge Mall Road, Pleasanton, California, 94588-3260
What is the 10x Genomics Inc website address?
The website address for 10x Genomics Inc is www.10xgenomics.com
Which industry sector does 10x Genomics Inc operate in?
10x Genomics Inc operates in the Biotechnology & Life Sciences sector

TXG Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock